Skip to main content
. 2021 Mar 6;21:238. doi: 10.1186/s12885-021-07968-5

Fig. 2.

Fig. 2

a Survival stratified by Recurrent sequence (Time from diagnosis of liver metastases). b Survival stratified by Recurrent sequence (Time from metastasis). c Overall Survival Among Patients of Breast Cancer Liver Metastases with targeted therapy stratified by subtype (FUSCC). d Overall Survival Among Patients of Breast Cancer Liver Metastases without targeted therapy stratified by subtype (FUSCC)